Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Harrison

Showing results (1411-1420 of 1,464) with videos related to

Pageof 147
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II TrialRobert J Motzer, Brian I Rini, David F McDermott, et al.
Development (Cambridge, England)|January 28, 2022
Heterogeneous pdgfrb+ cells regulate coronary vessel development and revascularization during heart regenerationSubir Kapuria, Haipeng Bai, Juancarlos Fierros, et al.
Journal of Medicinal Chemistry|September 13, 2018
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase InhibitorsJustin R Harrison, Stephen Brand, Victoria Smith, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2022
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)Michael R Harrison, Paul G Davis, Michel G Khouri, et al.
Biomarker Research|November 4, 2021
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinomaMatthew D Tucker, Landon C Brown, Yu-Wei Chen, et al.
Aging Cell|October 22, 2025
Protein Catabolites as Blood-Based Biomarkers of Aging Physiology: Findings From the Dog Aging ProjectBenjamin R Harrison, Maria Partida-Aguilar, Abbey Marye, et al.
Physics in Medicine and Biology|November 17, 2020
Out-of-field doses for scanning proton radiotherapy of shallowly located paediatric tumours-a comparison of range shifter and 3D printed compensatorA Wochnik, L Stolarczyk, I Ambrožová, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter studyNieves Martinez Chanza, Wanling Xie, Majd Issa, et al.
European Urology Oncology|July 6, 2024
Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR TrialTian Zhang, Lauren Howard, Bridget F Koontz, et al.
Cancer Medicine|September 15, 2023
Assessing the utility of molecular diagnostic classification for cancers of unknown primaryElle C Moore, Gerard C Blobe, Nicholas C DeVito, et al.
Pageof 147

Showing results (1411-1420 of 1,464) with videos related to

Sort By:
Pageof 147
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II TrialRobert J Motzer, Brian I Rini, David F McDermott, et al.
Development (Cambridge, England)|January 28, 2022
Heterogeneous pdgfrb+ cells regulate coronary vessel development and revascularization during heart regenerationSubir Kapuria, Haipeng Bai, Juancarlos Fierros, et al.
Journal of Medicinal Chemistry|September 13, 2018
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase InhibitorsJustin R Harrison, Stephen Brand, Victoria Smith, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2022
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)Michael R Harrison, Paul G Davis, Michel G Khouri, et al.
Biomarker Research|November 4, 2021
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinomaMatthew D Tucker, Landon C Brown, Yu-Wei Chen, et al.
Aging Cell|October 22, 2025
Protein Catabolites as Blood-Based Biomarkers of Aging Physiology: Findings From the Dog Aging ProjectBenjamin R Harrison, Maria Partida-Aguilar, Abbey Marye, et al.
Physics in Medicine and Biology|November 17, 2020
Out-of-field doses for scanning proton radiotherapy of shallowly located paediatric tumours-a comparison of range shifter and 3D printed compensatorA Wochnik, L Stolarczyk, I Ambrožová, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter studyNieves Martinez Chanza, Wanling Xie, Majd Issa, et al.
European Urology Oncology|July 6, 2024
Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR TrialTian Zhang, Lauren Howard, Bridget F Koontz, et al.
Cancer Medicine|September 15, 2023
Assessing the utility of molecular diagnostic classification for cancers of unknown primaryElle C Moore, Gerard C Blobe, Nicholas C DeVito, et al.
Pageof 147